Medtronic Announces Immediate CFO Leadership Transition Amid Recent SEC Filing
Medtronic
Medical Device Manufacturer
Source: Medical Device Business Review
This morning (March 18, 2025), Medtronic announced a significant change in its financial leadership.
Former Senior Vice President, Global Chief Financial Officer and Chief Accounting Officer Jennifer M. Kirk will officially leave on May 2, 2025.`, transitioning to CEO of privately held Exubrion Therapeutics`
Denise L. Blomquist, current Vice President, will assume the role effective March 17, 2025, ensuring a smooth transition of responsibilities.
Left: Jennifer M. Kirk, former Senior Vice President, Global Controller and Chief Accounting Officer of Medtronic
Right: Denise L. Blomquist, current Vice President of Medtronic, Global Financial Controller, and Chief Accounting Officer
Ms. Kirk stated that her departure was a personal career choice and had no disagreements with Medtronic's operations, policies, or management.
Blomquist, a graduate of the "Public Ivy" University of Wisconsin-Madison, succeeded her.Joined Medtronic in 2004, held several key financial positions, and in recent years has been overseeing global financial systems and process controls.
Resume of Denise L. Blomquist
Image source: LinkedIn
Ms. Blomquist's future compensation system includes:
√ Base Salary
√ Short-term Incentive Plan (MIP)
√ Long-Term Incentive Plan (LTIP, 2021 Edition)
√ Executive Equity Portfolio
Medtronic's Compensation Committee will conduct a systematic review of Ms. Blomquist's short-term incentive plan (MIP) and long-term incentive plan (LTIP) based on the annual evaluation mechanism. Her equity incentive measures will follow the standardized agreement framework applicable to senior executives of the company.
Following Ms. Blomquist's new appointment, members of Medtronic's senior management, including the Chief Financial Officer, Treasurer, and Chief Financial Analyst, have extended their welcome and congratulations in the comments section of her LinkedIn post.
The content of this article is for reference only and does not constitute investment advice. Readers are expected to effectively distinguish.If any platform reprints this article, it must take responsibility for the content of the article itself. Medical Device Business Review is not responsible for any impact caused by secondary dissemination after reprinting.
*Advertisement
▼More Book Recommendations▼
In order not to miss any content, everyone remembers toMedical Device Business ReviewSet as starred? Oh,
Looking forward to meeting you at the earliest opportunity each time.
